Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Healthcare Biotechnology
Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform developed at its laboratory facility in France. Through its wholly owned subsidiary TFChem S.A.R.L., the Company specializes in stabilizing carbohydrate molecules. The principal activities of the Company include development of cosmetic and pharmaceutical active ingredients. TFChem develops and markets its GlycoMim technology for pharmaceutical and biotechnology comp anies. TFChem’s proprietary chemistry technology can be applied to the development of several pharmaceutical domains such as cancer, diabetes, pain and inflammation and cardio-vascular diseases. Its cosmetic therapeutic area includes skincare-dark spot corrector (Rx & OTC), cell preservation and repair (including keloid and scar therapy), skincare-anti aging/anti-wrinkle and skincare-cellulite treatment. It has developed an active ingredient, TFC-1067 for the treatment of Dyschromia (Dark spots on the skin).


TSXV:SBM - Post by User

Sirona Biochem Corp
Bullboard Posts
User Avatar Image
(1)
•••
Post by Geheimnisvolleron May 07, 2019 6:27pm
211 Views
Post# 29722087

It gets more excited with day to day ...

It gets more excited with day to day ...https://sedar.com/FindCompanyDocuments.do 29. April

Date: April 29, 2019

To: All Canadian Securities Regulatory Authorities

Subject: Sirona BioChem Corp.

Dear Sir/Madam:

510 Burrard St, 3rd Floor Vancouver BC, V6C 3B9www.computershare.com

page1image3657159312

We advise of the following with respect to the upcoming Meeting of Security Holders for the subject Issuer:

Meeting Type :
Record Date for Notice of Meeting :
Record Date for Voting (if applicable) :
Beneficial Ownership Determination Date :
Meeting Date :
Meeting Location (if available) : IssuersendingproxyrelatedmaterialsdirectlytoNOBO: Issuer paying for delivery to OBO:

Notice and Access (NAA) Requirements:

NAA for Beneficial Holders NAA for Registered Holders

Voting Security Details: Description

COMMON SHARES

Sincerely,

Computershare

Agent for Sirona BioChem Corp.

Annual General Meeting May 15, 2019
May 15, 2019
May 15, 2019

June 20, 2019 Vancouver, BC No
No

No No

CUSIP Number ISIN

82967M100 CA82967M1005


Bullboard Posts
Dealroom for high-potential pre-IPO opportunities